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Functional heterogeneity of ROMK mutations linked to hyper- Transport of potassium ions (K1) through the renal epi-
prostaglandin E syndrome. thelia plays a key role in potassium balance [1]. Further-
Background. The renal K1 channel ROMK (Kir1.1) con- more, secretion of K1 from the epithelial cell into thetrols salt reabsorption in the kidney. Loss-of-function muta-
tubular lumen is essential for NaCl reabsorption via thetions in this channel cause hyperprostaglandin E syndrome/
Na-K-2Cl cotransporter in the thick ascending loop ofantenatal Bartter syndrome (HPS/aBS), which is characterized
by severe renal salt and fluid wasting. Henle (TAL) [2]. Efforts to identify molecules responsi-
Methods. We investigated 10 HPS/aBS patients for muta- ble for renal K1 secretion led to cloning of the ROMK
tions in the ROMK gene by single-strand conformation poly-
channel (renal outer medullary K1 channel; also termedmorphism analysis (SSCA) and direct sequencing. To assess
Kir1.1) [3]. Three ROMK isoforms have been identified,the functional consequences, Ba21-sensitive K1 currents were
measured in five mutants of the core region as well as one with ROMK1 and ROMK3 having their N-termini ex-
mutant with truncated C-terminus, using the two-electrode tended by 19 and 17 residues, respectively, as compared
voltage-clamp technique after an injection of mutant cRNA with ROMK2 [4]. The rat homologues are expressed dif-into Xenopus oocytes.
ferentially along the loop of Henle and the distal nephronResults. Three novel ROMK mutations were identified to-
gether with six mutations described previously. The mutations [5]. Mutations in the ROMK channel gene, KCNJ1, re-
were categorized into three groups: (1) amino acid exchanges sult in hyperprostaglandin E syndrome/antenatal Bartter
in the core region (M1-H5-M2), (2) truncation at the cytosolic syndrome (HPS/aBS) [6, 7], thereby indicating the im-C-terminus, and (3) deletions of putative promoter elements.
portance of ROMK for salt reabsorption in the TAL. Af-While the core mutations W99C, N124K, and I142T led to sig-
fected individuals possess the typical pattern of impairednificantly reduced macroscopic K1 currents (1 to 8% of wild-
type currents), the A103V and P110L variants retained sub- TAL function, including saliuretic polyuria, impaired
stantial K1 conductivity (23 and 35% of wild-type currents, urine concentration ability, and hypercalciuria [8, 9].
respectively). Coexpression of A103V and P110L, resembling
ROMK belongs to a family of structurally and func-the compound heterozygous state of the affected individual,
tionally related K1 channels designated as Kir channelsfurther reduced macroscopic currents to 9% of the wild-type
currents. All mutants in the core region exerted a dominant- [10]. Kir channels are assembled from four subunits.
negative effect on wild-type ROMK1. The C-terminal frame- Hydropathy and sequence analyses predict cytoplasmic
shift (fs) mutation (H354fs) did not change current amplitudes
N- and C-termini with a well-conserved core region,compared with ROMK1 wild type, suggesting that a mechanism
which consists of two transmembrane helices, M1 andother than alteration of the electrophysiological properties may
responsible for loss of channel activity. M2, flanking a pore-forming H5 segment containing the
Conclusions. Analysis of ROMK mutants linked to HPS/aBS selectivity filter for potassium ions (G-Y/F-G-motif) and
revealed a spectrum of mechanisms accounting for loss of chan- a flexible linker region between M1 and H5 [3]. ROMKnel function. Further characterization of the molecular defects
subunits form homotetrameric assemblies. However,might be helpful for the development of new therapeutic ap-
proaches. heterotetrameric assemblies together with Kir4.1 (also des-
ignated as Kir1.2) and Kir4.2 (also designated as Kir1.3)
subunits have also been reported [11, 12]. In addition, itKey words: K1 channel, channelopathy, antenatal Bartter syndrome,
KCNJ1 gene, renal fluid wasting, salt reabsorption. has been suggested that ROMK interacts with cystic
fibrosis transmembrane conductance regulator (CFTR),Received for publication August 3, 2000
a member of the ATP binding cassette (ABC)-trans-and in revised form November 6, 2000
Accepted for publication November 13, 2000 porter family, to form adenosine 59-triphosphate (ATP)-
sensitive potassium channels in renal epithelial cells [13].Ó 2001 by the International Society of Nephrology
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Kir channels are characterized by their ability to con- Mutational analysis
duct K1 more readily in the inward than the outward Genomic DNA of all affected individuals and avail-
direction. ROMK is a weakly rectifying K1 channel and able family members was extracted from whole blood
is gated by intracellular pH with acidification leading to using standard methods [19]. Previously reported primer
channel closure [14]. A molecular triad composed of the pairs and polymerase chain reaction (PCR) conditions
intracellular residues R41-K80-R311 was found to be a were applied for amplification of the coding region of
prerequisite for channel gating at physiological pH [15]. KCNJ1 [7]. For amplification of the promoter region and
Recent analysis of the functional consequences of nat- exons 1 to 3 of KCNJ1, four additional primer pairs were
urally occurring mutations in HPS/aBS contributed much designed (Table 1).
to the understanding of ROMK physiology. All point The KCNJ1 gene was screened for mobility shifts by
mutations linked to HPS/aBS were found in exon 5, SSCA [20]. Electrophoretic separation of the single-
which encodes the main part of the protein and is com- strand DNA was performed in a 10% polyacrylamide
mon to all ROMK isoforms. Thus, all ROMK channels gel (Clean Gel; Pharmacia Biotech, Quebec, Canada)
along the nephron will be affected by the mutations. using the Multiphor II electrophoresis system (Phar-
When expressed in COS-7 cells, ROMK variants harbor- macia Biotech) with 18 W constant power for one hour
ing mutations in the core region showed no significant at two temperatures, 98C and 158C. The band patterns
macroscopic potassium currents, whereas mutations oc- were visualized using the silver staining method (Plus-
curring in the N- and C-termini infrequently expressed One DNA silver staining kit; Amersham Pharmacia,
very low current levels [16]. The dominant-negative Arlington Heights, IL, USA). Direct sequencing was
N124K mutation in the linker region between M1 and performed after reamplification of the remaining PCR
the H5 region was found to abolish the expression of product using 59-Cy5–labeled primers on the ALF ex-
functional channels, suggesting an important role of this press sequencing system (Pharmacia Biotech) following
residue for channel assembly [12]. Two C-terminal muta- the protocols provided by the manufacturer. DNA se-
tions, which were located nearby or inside the putative quences were confirmed by sequencing both strands from
protein kinase A (PKA) phosphorylation site at position the patient, the parents, and a healthy control. Mutations
S219, showed a decreased open probability of the chan- were discerned from innocuous polymorphisms by de-
nel either by accelerating channel rundown or by induc- monstration of their absence in 100 control alleles.
ing long closed states [17, 18]. Recently, several muta- To detect the cytosine insertion at nucleotide 1116 (ac-
tions located in the intracellular N- and C-termini were cording to GenBanke U12541), we designed a mutagenic
shown to alter pH-dependent gating [15]. Most of these reverse primer (59-ATAAAGGCACATGGCACAGT
mutants encoded functional channels, but their pH gat- GACGG-39, Taneal 668C) introducing a cleavage site for
ing was shifted to more alkaline pH values. These shifts the endonuclease Asp I (Boehringer Mannheim, Mann-
in pH gating are proposed to result from disruption of heim, Germany) in the mutant allele but not in the wild
the R41-K80-R311 triad or from mutation-induced struc- type. After digestion of the PCR product at 378C for
tural disturbances of this arrangement. three hours, the samples were applied on a 10% poly-
Our study describes three novel mutations in ROMK, acrylamide gel, separated in the electric field (600 V,
along with six mutations reported previously. Six mutant 18 W) and subsequently silver stained.
variants were electrophysiologically characterized. Tak-
Haplotype constructioning previous findings into consideration, analyses of natu-
rally occurring ROMK mutations revealed distinctly dif- Haplotype construction was performed using four poly-
ferent mechanisms related to loss of channel function. morphic markers closely linked to the KCNJ1 locus on
chromosome 11q24-25 (D11S912, D11S4150, D11S4131,
D11S910). Haplotype analysis followed previously pub-METHODS
lished protocols [7].
Patients
Mutagenesis and expression systemMutational analysis was performed in 10 patients diag-
nosed for HPS/aBS following the criteria of Seyberth et For expression in Xenopus oocytes, the human ROMK1
al [9]. Laboratory data were obtained from the hospital cDNA cloned into the polyadenylating oocyte-expres-
records. Prior to enrollment in the study, the SLC12A1 sion vector pSGEM (a gift of M. Hollmann, Go¨ttingen,
gene encoding NKCC2 was excluded as a disease-causing Germany) was used. Site-directed mutagenesis was per-
gene by either haplotype analysis or single-strand confor- formed using 25-mer oligonucleotide primers with the en-
mation polymorphism analysis (SSCA). This study was ap- gineered nucleotide changes in the center of the primer
proved by the local ethics committee, and informed con- (leading to amino acid changes W99C, A103V, P110L,
N124K, I142T, and H354fs) and a commercial kit (Quiksent was obtained from the patients and/or their parents.
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Table 1. Primer pairs and annealing temperatures for analysis of the 59 part of KCNJ1
Forward primer (59!39) Reverse primer (59!39) Tanneal
KCNJ1 59 CATCCCATATTCATTATTTCATTC CCCAAGGAGCCCCTCACAAA 608
KCNJ1 exon 1 CACGCCTACTCTTGTTGGAT CGGGGAAAAGAGGTCTAAAT 638
KCNJ1 exon 2 TTACCTTCACCCAAATGTCTT CGTCTATGCACCAAATCTGT 638
KCNJ1 exon 3 GTGGGCCTGTCCTCTGTCTC AGCCTGGGGTGTCCAATAGT 638
Changee; Stratagene, La Jolla, CA, USA) as described in the patients’ follow-up was 3.0 mmol/L. The patients’
ability to produce concentrated urine was severely im-by the manufacturer. The entire ROMK1 coding region
paired, and urinary calcium persisted at high levels. Eightwas sequenced in order to confirm that only the intended
out of 10 patients were treated with the cyclooxygenasenucleotide exchange had occurred. Capped run-off cRNA
inhibitor indomethacin with beneficial effects in termspolyA1 transcripts were synthesized from linearized
of reduction of saliuretic polyuria, partial or completecDNA using T7-RNA polymerase and injected in defolli-
resolution of hypokalemia, a decrease of urinary calciumculated oocytes. Three nanograms cRNA were injected
excretion, and better growth.for the expression of wildtype or mutant channels alone.
For coexpression of wild-type and mutant subunits, equiva-
Genetics: Missense mutationslent amounts of cRNA (3 ng cRNA each) were injected,
Two novel missense mutations were identified (I andallowing a comparison of whole cell currents from coin-
II) together with four missense mutations previously de-jected oocytes and oocytes expressing wild-type or mutant
scribed in HPS/aBS patients (III through VI; Table 2).ROMK alone. Oocytes were incubated at 208C in ND96
The novel point mutations represent an exchange fromsolution (96 mmol/L NaCl, 2 mmol/L KCl, 1 mmol/L
alanine-103 to valine and from isoleucine-142 to threo-MgCl2, 1 mmol/L CaCl2, HEPES, pH 7.4) supplemented
nine. A103 is located in the transmembrane domainwith 100 mg/mL of gentamycin and 2.5 mmol/L sodium
M1, and I142 is directly adjacent to the selectivity filterpyruvate. Electrophysiological measurements were per-
in the pore region. Both residues are highly conservedformed 48 hours after injection.
within the Kir family.
Three additional missense mutations detected in ourElectrophysiological procedures
patients affect the core region of the K1 channel: TheTwo-electrode voltage-clamp measurements were per-
W99C mutant alters the M1 domain, while P110L and
formed as described earlier [12] using a Turbo Tec-10 C N124K alter the extracellular linker between M1 and
amplifier (npi; Germany) and sampled through an EPC9 H5. Only one missense mutation was found in the intra-
interface (Heka Electronics, Lamprecht, Germany) us- cellular C terminus, substituting glycine for valine at
ing PULSE/PULSEFIT software for data acquisition and codon 315.
IGOR software for data analysis.
Nonsense mutations
Two patients (VI and VII) were found to carry a 4 bpRESULTS
deletion spanning the last base of codon T332 and all ofPatients
codon K333. This mutation was previously described in
The patient cohort consisted of three offspring of con- two unrelated HPS/aBS patients [6, 7]. Since a relation-
sanguineous unions and seven sporadic cases. In each ship between these families was not apparent, the high
case, both mutant alleles have been identified. The ge- prevalence of this mutation may reflect a particular sus-
netic data and the corresponding phenotypes are summa- ceptibility of this genomic site.
rized in Table 2. The phenotype of patient V has been We originally failed to detect the second disease-caus-
reported previously [9, 21, 22]. All patients were born ing mutation in three patients (III through V). Therefore,
prematurely with a median gestational age of 32 weeks. direct sequencing of the coding region of KCNJ1 was
Postnatally, renal salt losses led to a drop of plasma performed. All three patients turned out to carry the same
sodium to a minimum value of 125 mmol/L (median). insertion of a single cytosine base in a polycytosine tract
Three out of 10 patients exhibited transitory, marked spanning codons 352 and 353, resulting in a frameshift
hyperkalemia (plasma K1 levels .7 mmol/L) in the neo- mutation and altering the encoded protein from amino
natal period. During follow-up, eight patients developed acid 354 onward, ending at a new stop codon at position
hypokalemic alkalosis secondary to hyperaldosteronism. 362. As we missed this mutation by our SSCA screening,
The time of onset of hypokalemic alkalosis varied consid- we designed a mutagenic reverse primer introducing an
erably from one week up to five years of age. In patients Asp I cleavage site in the mutant allele. Subsequent
IV and VII, hypokalemic alkalosis was not observed at digestion of the PCR product then enabled us to detect
the three patients together with one additional patientany time. The median minimal potassium level recorded
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Table 2. Genetic and phenotypic characteristics of ten HPS/aBS patients enrolled into the study
Min. Na1 level
Polyhydramnios/ (mmol/L)/ Max. K1 leveld Min. K1 level
Age at diagnosis/ gestational age Na1 suppl. Urinary osmolality Hypercalciuria
Patient Mutation major clinical signs weeks (mmol/kg/day) mmol/L mmol/kg mg/kg/day
I A103V 4 years/nephrocalcinosis 2/33 128/7 5.4 3.3 285–431 13
P110L
II I142T 2 months/hypokalemia, 1/30 116/ND 9.4 2.3 180–318 Ca/Crea (mol)
P110L hyponatremia, 3
nephrocalcinosis
III W99C 1 month/polyuria, 1/35c 132/10 5.2 3.1 107–236 7.8
1116insC!362X hyponatremia
IV N124K 9 months/fever, 1/28 ND/40 9 3.7 122–337 14
1116insC!362X nephrocalcinosis
V V315G 8 months/dystrophia, 1/30 129/12 6.5 2.2 63–340 9.5
1116insC!362X fever
VI V315G 2 months/polyuria, 1/32 124/15 6.3 3.0 195 10.5
1053delAAAG!368X hyponatremia
VIIa 1053delAAAG!368Xb 13 months/dystrophia 1/36 126/ND 4.4 3.8 ,300 Ca/Crea (mol)
2.6
VIII 1116insC!362Xb 2 months/hypokalemia, 1/29 124/ND 8.2 3.0 127–335 12.8
hyponatremia,
nephrocalcinosis
IXa del ex1-2b 1 month/polyuria, 1/32 128/22 4.8 3.0 255–305 Ca/Crea (mol)
hypokalemia 4.7
Xa del ex1-2b 1 month/polyuria, 1/34 125/8 4.8 2.8 ND 25
nephrocalcinosis
Novel mutations are indicated by bold letters; nucleotides are numbered according to GenBank accession number U12541.
a Offsprings of consanguineous unions
b Homozygous
c Received indomethacin between 28 and 31 weeks of gestation
d Average of the three highest plasma K1 values within the first four weeks of life
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Fig. 1. Detection of a single cytosine inser-
tion at residue P353. Electrophoretical separa-
tion of the “modified” polymerase chain reac-
tion (PCR) fragments after digestion with Asp
I in a 10% polyacrylamide gel. Only amplifi-
cation products of the mutant allele were
digested, leading to an additional band at
100 bp. In addition to the three heterozygotes,
we detected a patient harboring this variant
on both paternal alleles (VIII, digestion not
complete). Direct sequencing of patients III
and VIII confirms the cytosine insertion and
the resulting frameshift (H354fs) in heterozy-
gous and homozygous state, respectively.
(VIII) having a homozygous cytosine insertion (Fig. 1).
This variant was not seen in 100 unaffected subjects.
The frequent insertion of a cytosine in a polycytosine
tract [that is, (C)41112-15 according to GenBank acces-
sion number U12541] might reflect a susceptibility of this
mononucleotide repeat tract to mutations from “slipped
strand mispairing.” On the other hand, because all pa-
tients carrying the cytosine insertion originated from
Germany, the high frequency of this mutation may also
be attributable to a founder effect. Indeed, four of five
affected chromosomes share the same polymorphism
Fig. 2. Demonstration of the large deletion of the 59 part of KCNJ1.with respect to the D11S4150 microsatellite, which is
(Bottom) Genomic organization of the KCNJ1 gene, which consists oflocated next to KCNJ1 (data not shown). Since the prev- five exons, with exon 5 encoding the main part of the channel protein.
alence of this D11S4150 variant in the normal German Alternative splicing of exons 1 to 4 accounts for the generation of three
protein isoforms. Two putative promoter elements are located in 59 ofpopulation was found to be less than 5%, these results
exon 1 and exon 4, respectively (s). (Left) Arrowheads at the 59 partare suggestive for a common ancestor. of KCNJ1 indicate the annealing sites for the primers used for deletion
detection. (Right) PCR products from patients, family members, and a
control separated on 1.5% agarose gel: (a) KCNJ1 59, (b) KCNJ1 59Deletion of exons 1 and 2
(forward) together with KCNJ1 exon 1 (reverse), (c) KCNJ1 exon 2;
In two unrelated patients (IX and X), each of them KCNJ1 exon 3 (Table 1).
having consanguineous parents, the haplotype data indi-
cated linkage to the KCNJ1 locus on chromosome 11p24
(data not shown). Since sequencing of exon 5 of the
of the predicted length were obtained in the parents andKCNJ1 gene did not reveal any abnormality, we subse-
nonaffected siblings as well as in a control subject (Fig. 2).quently analyzed the isoform-specific exons 1 to 4 and
A similar finding has recently been reported by Feld-the nearby transcription initiation sites. Amplification of
mann, Alessandri, and Deschenes [23].exons 3 and 4 from the patients’ genomic DNA resulted
in PCR products of the predicted length. In contrast, we
Electrophysiologyfailed to obtain the respective PCR product for exons 1
The electrophysiological properties of five mutationsand 2. Subsequent amplification using a primer pair
in the core region of ROMK1 (W99C, A103V, P110L,(KCNJ1 59) annealing almost 600 (forward) and 250 (re-
N124K, I142T) and a C-terminal frameshift mutationverse) bp upstream of exon 1 and, alternatively, using the
(H354fs) were analyzed by heterologous expression insame forward primer together with the reverse primer of
exon 1 yielded no PCR product either, whereas products Xenopus oocytes. When examined by two-electrode volt-
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Fig. 3. Quantitative analysis of the two ROMK mutations A103V and
P110L in Xenopus oocytes. (A) Original recordings show current re-
sponses of cRNA-injected oocytes to 500 ms voltage steps between 80
and 2140 mV from a holding potential of 0 mV [K1]e 5 96 mmol/L.
The inset diagrams illustrate the position of the two mutant residues
in the extracellular M1-H5 linker of the ROMK subunit. (B) Steady-
state current amplitudes derived from wild-type ( ) and mutant (h)
channels and a combination of both (j) measured at 2100 mV. When
expressed alone, 3 ng cRNA of ROMK1 variants were injected. For
coexpression, equimolar amounts of mutant or wild-type cRNA (3 ng
each) were coinjected. Values are discussed in the text. Errors are Fig. 4. Mean current amplitudes of wild-type and mutant ROMK chan-
mean 6 SD. nels in Xenopus oocytes. Amplitudes are steady-state currents generated
by mutant and equimolar mutant/wild-type channels measured at 2100
mV in 96 extracellular K1. Figure 3 discussed the amounts of injected
cRNAs. As a control, coexpression of the Kir5.1 subunit did not signifi-
cantly change ROMK currents. Note that Kir5.1 has to assemble withage-clamp, all mutant ROMK1 channels carrying the
Kir4.1 or Kir4.2 subunits for functional expression [24, 25]. Coexpressionindividual core mutation showed a significant but vari- of wild-type and H354fs mutant did not result in a further increase in
able decrease in macroscopic inward currents when com- currents probably due to saturating amounts of cRNA injected. Symbols
are: (j) mutant 1 wild-type; (h) mutant.pared with wild-type ROMK1. With the extracellular K1
concentration raised to 96 mmol/L, wild-type ROMK1
current amplitudes averaged 250.6 6 8.0 mA (N 5 9)
at 2100 mV membrane potential. In contrast, the two amplitudes of mutant N124K and I142T. In patient II
mutations present in patient I, A103V (211.5 6 2.7 mA, (I142T/P110L), where both alleles were affected by mu-
N 5 9) and P110L (218.5 6 3.9 mA, N 5 7), reduced tations of the core region, channel function was likely
macroscopic current amplitudes to 23 and 35%, respec- to be severely impaired: macroscopic currents observed
tively, under the same recording conditions (Fig. 3). after coinjection of I142T/P110L averaged approxi-
When these ROMK1 mutants were coexpressed with mately 1% of the wild-type ROMK1 current (20.6 6
equal amounts of wild-type cRNAs (100% each of con- 0.3 mA, N 5 10). It should be noted that in all cases,
trol), macroscopic currents were not significantly differ- quantitatively similar results have been obtained after
ent compared with the mutants alone (A103V/WT: transient channel expression in COS-7 cells (data not
29.8 6 2.6 mA, N 5 7; P110:/WT: 217.9 6 8.2 mA, N 5 shown).
7), indicating a dominant negative effect. However, the In contrast, expression of the C-terminal frameshift
expression of both mutant ROMK1 subunits together, mutation (H354fs) in oocytes (and COS-7 cells, data not
mimicking the compound heterozygous state of patient I, shown) did not result in decreased macroscopic currents
resulted in macroscopic currents with significantly when compared with wild type (257.2 6 17.8 mA, N 5
smaller amplitude than were found for either of the two 10). This demonstrates that the electrophysiological
mutations alone (A103V/P110L: 24.5 6 2.2 mA, N 5 properties of this mutation are unlikely to be responsible
10; 9% of wild-type current; Fig. 3). for the HPS/aBS phenotype.
Whole-cell currents of oocytes expressing ROMK1
channels carrying the mutations W99C (20.8 6 0.5 mA,
DISCUSSIONN 5 10), N124K (23.9 6 1.2 mA, N 5 5), or I142T
(20.5 6 0.4 mA, N 5 10) were even more dramatically This study confirms that mutations in the potassium
channel ROMK are a common cause of HPS/aBS and,reduced to 2, 8, and 1%, respectively (Fig. 4). Interest-
ingly, deficient W99C channels were partially rescued by in addition, that the molecular defects underlying the loss
of channel activity are heterogenous. Based on the func-wild-type ROMK1 (229.1 6 15.4 mA, N 5 10; Fig. 4),
whereas equimolar coinjection of wild-type ROMK1 tional consequences, three major classes of mutations
were recognized in this study: (1) point mutations in thecRNA did not significantly alter macroscopic current
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core region, (2) truncating mutations in the C-terminus,
and (3) deletions of putative promoter elements.
Mutations in the core region are either located in the
highly conserved channel pore or in the less conserved
M1-H5 linker region. In the hydrophobic M1 segment,
the loss-of-function phenotype may be caused by intro-
ducing bulky (A103V) or polar (W99C) amino acids.
Another possible mechanism is the impairment of the
selectivity filter by changes of the residues adjacent to
the GYG-motif (I142T). It is less clear, however, how
mutations in the extracellular loop would disturb channel
function (P110L, N124K). Our data on the P110L and
N124K mutations together with previous results on a
nearby mutation (D108H) [16] suggest that the tertiary
structure of the entire extracellular loop, although not
directly involved in pore formation, is essential for chan-
Fig. 5. Distribution and clustering of missense mutations in the ROMKnel function. Thus, certain amino acid substitutions may
channel molecule. Residues changed in HPS/aBS patients are indicated
be sterically incompatible with a functional pore struc- by filled circles (d). Mutations are grouped in clusters I-V, which con-
tribute to distinct biophysical properties of the channel molecule. Theture. Indeed, a compact folding of the extracellular loop
lines between clusters II, IV, and V indicate putative interactions be-is supported by the crystal structure of the Streptomyces
tween the residues responsible for pH-dependent gating.
lividans K1 channel [26].
Two mutants in the core region, A103V and P110L,
retained substantial macroscopic potassium currents,
which seemed to be inconsistent with their proposed physiologically relevant K1 conductance in the TAL.
Genetically, however, transmission of HPS/aBS is reces-pathogenic role at first sight. However, our HPS/aBS pa-
tients, as well as an additional one described previously sive, and heterozygous carriers of ROMK mutations do
not suffer from the disease. This discrepancy might be[7], which were affected from the P110L exchange, were
found to be compound heterozygotes, harboring a differ- explained by up-regulated transcription of wild-type al-
leles or the ability of wild-type ROMK subunits to forment mutation on the second parental allele. In the oocyte
system, coexpression of the A103V and P110L mutants heterotetramers with other members of the Kir family,
such as Kir4.1 and Kir4.2 [11, 12].(a condition as in patient I) resulted in significantly
smaller macroscopic currents as compared with the cur- Only the W99C mutant showed a significant increase
in macroscopic current when coexpressed with wild-typerents from each mutant separately. Possibly, the close
proximity of the two residues gives rise to major struc- subunits. Two explanations are possible: (1) Mutant and
wild-type assemble and tetrameric channels containingtural changes in the linker region. Moreover, a combina-
tion of P110L with I142T (patient II) resulted in 20 times one or more W99C subunits are functional to certain
extent (partial rescue), and/or (2) oligomerization be-lower macroscopic currents as compared with P110L/
A103V. The residual potassium conductance in P110L/ tween wild-type and W99C subunits is impaired, re-
sulting in a significantly higher amount of “pure” wild-A103V may account for the milder phenotype of patient
I (Table 2). We therefore suggest that the combination type tetramers than assumed by a 1:1 stoichiometry.
Together with the two novel pore mutations, 21 differ-of mutations in KCNJ1 may be a crucial determinant of
the severity of the phenotype. However, examination of ent missense mutations have been described to date,
distributed throughout the channel protein (Fig. 5). Theymore patients are needed before a reliable correlation
between genotype and phenotype can be established. are tentatively grouped in five clusters: (1) within the
channel core region (aa 84-180), (2) in the cytosolicIt is interesting to note that the majority of the core
region mutations exerted a dominant negative effect, N-terminal domain (aa 40-60), (3) nearby lysine-80 (aa
70-80), (4) in the ATP-binding regulatory domain (aademonstrating that the mutant channels are synthesized
and capable for oligomerization. In the tetrameric assem- 190 to 240) C-terminal to M2, and (5) in the C terminus
around R311. Mutations in the core region reduces K1bly of ROMK, one mutated subunit may be sufficient
to impair channel function. This is in accordance with conductance to a various extent, as demonstrated in this
study. The majority of mutations in clusters (2), (3), andfunctional data obtained from ROMK1 core region dele-
tion mutants [27]. Statistically, assuming a 1:1 stoichiom- (5) have been argued to change the structural arrange-
ment of the pH sensor and shift the pH gating to moreetry of mutant and wild-type subunits, only 1 out of 16
tetrameric channels should be composed of four wild- alkaline pH values [15]. Mutations in cluster (4) may
abolish PKA phosphorylation, which was found to lowertype subunits. This ratio may be too low to maintain a
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the affinity for phosphatidylinositol lipids [28] and thus hypothesis because both patients were diagnosed very
early, and appropriate treatment with indomethacin andmay account for a decline of channel open probability
[18]. Moreover, it has been demonstrated that removal potassium supplementation, respectively, was introduced
from that time on. The data from rats further suggest thatof target sites for PKA (for example, S219) shifted pH
gating off the physiological range [15], thus establishing ROMK2 and ROMK3 specifically mediate K1 recycling
in the TAL, ensuring that an adequate supply of luminala common pathogenic principle among the four intracel-
lular clusters. potassium is provided for efficient function of the Na-
K-2Cl cotransporter. Again, this is consistent with theIn contrast to the missense mutations, the C-terminal
frameshift mutation (H354fs) resulted in macroscopic cur- patients’ clinical presentation, including saliuretic poly-
uria and hypercalciuria as a consequence of defectiverents with amplitudes comparable to wild-type ROMK
and virtually unaffected biophysical properties. We spec- NaCl reabsorption in the TAL.
Various ROMK mutations affect residues critical forulate that other mechanisms, for example, incorrect tar-
geting to the apical membrane in epithelial cells or in- channel function, some of them related to previously
recognized channel properties, others revealing new as-compatibility with interaction partners, such as CFTR
and other Kir subunits, are responsible for the HPS/aBS pects of channel function and regulation. The combina-
phenotype. In Kir2.3 channels, transfected into polarized tion of mutations in compound heterozygous subjects
MDCK cells, removal of the extreme C-terminus, which may not be arbitrary, but rather follow principles related
contains a consensus sequence for PDZ protein binding, to the tertiary or quaternary structure of the protein. A
caused mistargeting of the channel to the opposite mem- frequent dominant-negative effect of ROMK mutations,
brane (abstract; The Physiologist 42:A18, 1999). In resulting in a loss-of-function, is based on the tetrameric
ROMK channels, the role of the putative PDZ binding- assembly of the ROMK protein. A major challenge for
motif (TKM-Stop) has not yet been analyzed. Inter- future work in this field is to develop therapies directed
estingly, a recent report showed that removal of the at the restoration of channel function by targeting the
C-terminus at position aa331, also linked to HPS/aBS, underlying molecular defect.
resulted in a nonconductive channel [29]. Incremental
reconstruction of the C-terminus delimited aa332-351 as ACKNOWLEDGMENTS
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